Jamal Mahajna

9PUBLICATIONS
31CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsTraditional Chinese medicine and treatmentsCancer therapy (excl. chemotherapy and radiation therapy)Agricultural molecular engineering of nucleic acids and proteinsChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 04, 2026
Passenger variants as pan-clonal markers of pediatric AML: Implications for molecular MRD.

|Nov 27, 2024
Chaga Mushroom Triterpenoids Inhibit Dihydrofolate Reductase and Act Synergistically with Conventional Therapies in Breast Cancer.

Junbiao Wang, Daniela Beghelli, Augusto Amici

|Jul 13, 2024
Overcoming Chemoresistance in Cancer: The Promise of Crizotinib.

Sanaa Musa, Noor Amara, Adan Selawi

|Nov 25, 2023
Plant-Derived Epi-Nutraceuticals as Potential Broad-Spectrum Anti-Viral Agents.

Rosita Gabbianelli, Ehud Shahar, Gaia de Simone

|May 13, 2023
Secreted Soluble Factors from Tumor-Activated Mesenchymal Stromal Cells Confer Platinum Chemoresistance to Ovarian Cancer Cells.

Yifat Koren Carmi, Hazem Khamaisi, Rina Adawi

|Feb 15, 2022
2-Hydroxyestradiol Overcomes Mesenchymal Stem Cells-Mediated Platinum Chemoresistance in Ovarian Cancer Cells in an ERK-Independent Fashion.

Hazem Khamaisi, Hatem Mahmoud, Jamal Mahajna

Pageof 2

Frequent Collaborators

2 joint publications

Jacob Gopas

2 joint publications

Cristina Marchini

2 joint publications

Junbiao Wang

2 joint publications

Sanaa Musa